MS Speaks
Multiple Sclerosis => TREATMENTS => MAYZENT (siponimod) => Topic started by: agate on January 29, 2020, 09:35:32 pm
-
From the European Pharmaceutical Review (January 29, 2020), "European Commission Approves Mayzent for [Active] Secondary Progressive Multiple Sclerosis":
https://www.europeanpharmaceuticalreview.com/news/111603/ec-approves-mayzent-for-secondary-progressive-multiple-sclerosis/